CoChat

Identification of the di‐pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti‐tumour agents

Open access
Becker, Erika M, Lovejoy, David B, Greer, Judith M, Watts, Ralph, Richardson, Des R · 2003 · British Journal of Pharmacology
Cited by 103

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In an attempt to develop chelators as potent anti‐tumour agents, we synthesized two series of novel ligands based on the very active 2‐pyridylcarboxaldehyde isonicotinoyl hydrazone (PCIH) group. Since lipophilicity and membrane permeability play a critical role in Fe chelation efficacy, the aldehyde moiety of the PCIH series, namely 2‐pyridylcarboxaldehyde, was replaced with the more lipophilic 2‐quinolinecarboxaldehyde or di‐2‐pyridylketone moieties. These compounds were then systematically condensed with the same group of acid hydrazides to yield ligands based on 2‐quinolinecarboxaldehyde isonicotinoyl hydrazone (QCIH) and di‐2‐pyridylketone isonicotinoyl hydrazone (PKIH). To examine chelator efficacy, we assessed their effects on proliferation, Fe uptake, Fe efflux, the expression of cell cycle control molecules, iron‐regulatory protein‐RNA‐binding activity, and 3 H‐thymidine, 3 H‐uridine and 3 H‐leucine incorporation. Despite the high lipophilicity of the QCIH ligands and the fact that they have the same Fe‐binding site as the PCIH series, surprisingly none of these compounds were effective. In contrast, the PKIH analogues showed marked anti‐proliferative activity and Fe chelation efficacy. Indeed, the ability of these ligands to inhibit proliferation and DNA synthesis was similar or exceeded that found for the highly cytotoxic chelator, 311. In contrast to the PCIH and QCIH analogues, most of the PKIH group markedly increased the mRNA levels of molecules vital for cell cycle arrest. In conclusion, our studies identify structural features useful in the design of chelators with high anti‐proliferative activity. We have identified a novel class of ligands that are potent Fe chelators and inhibitors of DNA synthesis, and which deserve further investigation. British Journal of Pharmacology (2003) 138, 819–830. doi:10.1038/sj.bjp.0705089

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705089

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 103

Metadata

Authors
Becker, E. M., Lovejoy, D. B., Greer, J. M., Watts, R., & Richardson, D. R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-03
Volume
138
Issue
5
Pages
819-830
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2000302463
Cited by
103
References
3
FWCI
2.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.